Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1

Nature Communications

Volumn 4, Issue , 2013, Pages

  Cao, Yanan ^a   Gao, Zhibo ^b   Li, Lin ^b   Jiang, Xiuli ^a   Shan, Aijing ^a   Cai, Jie ^a   Peng, Ying ^a   Li, Yanli ^a   Jiang, Xiaohua ^a   Huang, Xuanlin ^b   Wang, Jiaqian ^b   Wei, Qing ^a   Qin, Guijun ^c   Zhao, Jiajun ^d   Jin, Xiaolong ^a   Liu, Li ^b   Li, Yingrui ^b   Wang, Weiqing ^a   Wang, Jun ^b,e,f,g   Ning, Guang ^a,h  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g University of Copenhagen   (Denmark)

^h SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR YY1;

DRUG; GENETIC VARIATION; GENOME; GLUCOSE; MUTATION; TUMOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EXOME; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENOTYPE; HUMAN; HUMAN TISSUE; INSULINOMA; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREATIC NEUROENDOCRINE TUMOR; PROTEIN DNA BINDING; SOMATIC MUTATION; ZINC FINGER MOTIF;

AMINO ACID SEQUENCE; ANIMALS; CASE-CONTROL STUDIES; CATTLE; CELL LINE; EXOME; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; HUMANS; INSULINOMA; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PANCREATIC NEOPLASMS; RATS; YY1 TRANSCRIPTION FACTOR;

EID: 84890657221     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3810     Document Type: Article

References (30)

1. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y. & Nordenskjöld, M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332, 85 (1988).
2. Jiao, Y. et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199-1203 (2011).
3. Karnik, S. K. et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318, 806-809 (2007). (Pubitemid 351411773)
4. Yang, Y. et al. Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene. Proc. Natl Acad. Sci. USA 107, 20358-20363 (2010).
5. Missiaglia, E. et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J. Clin. Oncol. 28, 245-255 (2010).
6. Fraenkel, M. et al. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57, 945-957 (2008).
7. Wang, Y., Liu, J., Liu, C., Naji, A. & Stoffers, D. A. MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic b-cells. Diabetes 62, 887-895 (2013).
8. Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873 (2010).
9. Choi, M. et al. K\+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768-772 (2011).
10. Zaravinos, A. & Spandidos, D. A. Yin yang 1 expression in human tumors. Cell Cycle 9, 512-522 (2010).
11. Shi, Y., Seto, E., Chang, L. S. & Shenk, T. Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67, 377-388 (1991). (Pubitemid 121001453)
12. Shi, Y., Lee, J. S. & Galvin, K. M. Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49-F66 (1997). (Pubitemid 27211616)
13. Cunningham, J. T. et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740 (2007). (Pubitemid 350207689)
14. Blättler, S. M. et al. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab. 15, 505-517 (2012).
15. Jeon, Y. & Lee, J. T. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 146, 119-133 (2011).
16. Houbaviy, H. B., Usheva, A., Shenk, T. & Burley, S. K. Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc. Natl Acad. Sci. USA 93, 13577-13582 (1996). (Pubitemid 26424161)
17. Riquet, F. B. et al. YY1 is a positive regulator of transcription of the Col1a1 gene. J. Biol. Chem. 276, 38665-38672 (2001).
18. Supale, S., Li, N., Brun, T. & Maechler, P. Mitochondrial dysfunction in pancreatic b cells. Trends Endocrinol. Metab. 23, 477-487 (2012).
19. Burks, D. J. & White, M. F. IRS proteins and beta-cell function. Diabetes 50(Suppl 1), S140-S145 (2001).
20. Kulke, M. H., Bergsland, E. K. & Yao, J. C. Glycemic control in patients with insulinoma treated with everolimus. N. Engl. J. Med. 360, 195-197 (2009).
21. Yao, J. C. et al. Everolimus for advanced pancreatic neuroendocrine tumors. N. Engl. J. Med. 364, 514-523 (2011).
22. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
23. Picard http://picard.sourceforge.net/(2013).
24. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
25. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
26. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
27. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
28. Miyazaki, J. et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126-132 (1990). (Pubitemid 20228111)
29. Zhou, L. et al. Berberine acutely inhibits insulin secretion from beta-cells through 30,50-cyclic adenosine 50-monophosphate signaling pathway. Endocrinology 149, 4510-4518 (2008).
30. PyMOL The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC http://www.pymol.org (2013).